ATP5C1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-ATP5C1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityATP5C1
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formatimmunogen affinity purified
Size0.03 mL, 0.1 mL, 0.2 mL
Concentration1 mg/ml
ApplicationsWestern Blot (WB), Immunohistochemistry (IHC) Paraffin, ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: ATP5C1 Polyclonal Antibody detects endogenous levels of ATP5C1 protein. ATP5C1 encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c
ImmunogenImmunogen: Synthesized peptide derived from the internal region of human ATP5C1 at AA range: 100-180
Other Names[Rabbit ATP5C1; ATP5C1; ATP5C; ATP5CL1; ATP synthase subunit gamma; mitochondrial; F-ATPase gamma subunit]
Gene, Accession #[ATP5C1], Gene ID: 509, NCBI: NP_001001973.1, UniProt: P36542
Catalog #MBS9701459
Price$130, $220, $325
Order / More InfoATP5C1 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.